Clinical trial
Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent…
NCT00134875 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00134875 |
|---|---|
| Title | Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers |
| Official title | Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | Buprenorphine/naloxone |
| Enrollment | 9 |
| Start date | Dec 1, 2000 |
| Primary completion | Dec 1, 2002 |
| Completion | Dec 1, 2017 |
| First posted | Aug 25, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: